Combination of 131I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of 131I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma
Authors
Keywords
-
Journal
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2018-05-17
DOI
10.1080/13102818.2018.1475254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma
- (2017) Chun-yu Huang et al. JOURNAL OF IMMUNOTHERAPY
- TGF-β signalling and liver disease
- (2016) Isabel Fabregat et al. FEBS Journal
- miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5-fluorouracil by targeting EIF4E
- (2016) Xiaoyan Yang et al. ONCOLOGY REPORTS
- Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
- (2016) Massimiliano Berretta et al. Frontiers in Pharmacology
- Cancer prevention and therapy through the modulation of the tumor microenvironment
- (2015) Stephanie C. Casey et al. SEMINARS IN CANCER BIOLOGY
- Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil
- (2015) Kazuomi Ueshima et al. Liver Cancer
- The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma
- (2014) Fan Wang et al. PLoS One
- Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
- (2014) Hidekazu Kawashima TheScientificWorldJOURNAL
- Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma
- (2014) Chong-Ling Duan et al. TUMOR BIOLOGY
- Endoglin for Targeted Cancer Treatment
- (2014) Lee S. Rosen et al. Current Oncology Reports
- Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition
- (2013) Lu He et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells
- (2013) WEI GU et al. ONCOLOGY REPORTS
- Self-Assembled Multivalency: Dynamic Ligand Arrays for High-Affinity Binding
- (2012) Anna Barnard et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials
- (2012) Ping Fang et al. PLoS One
- Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab
- (2011) Alexandra D. Jensen et al. CANCER
- Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST)
- (2011) Tao Jiang et al. INVESTIGATIVE RADIOLOGY
- Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab
- (2011) Beom-Su Jang et al. NUCLEAR MEDICINE AND BIOLOGY
- New Antibody Conjugates in Cancer Therapy
- (2011) Serengulam V. Govindan et al. TheScientificWorldJOURNAL
- The emerging role of TGF-β superfamily coreceptors in cancer
- (2009) Carmelo Bernabeu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pathogenesis of hepatocellular carcinoma and molecular therapies
- (2009) Beatriz Mínguez et al. CURRENT OPINION IN GASTROENTEROLOGY
- A prospective study of macrophage migration inhibitory factor as a marker of inflammatory detection
- (2008) Chao Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now